plateau on semaglutide The GLP-1 Plateau: What It Is and How to Get Past It Why Weight Loss Plateaus on

CrossRef Selenoprotein P deficiency in MASLD: association with insulin resistance and liver fibrosis: a prospective case-control study Mona A Hegazy, Samar Saad Mohamed, Eman H Saad, Ahmed Abdelghani, Dalia Abd el Fattah, Mohamed Ahmed Elsayed Mekki, Mona Fathy, Nora Hassan, Omar Ashoush BMC Gastroenterology .2026;[Epub] CrossRef MASLD and sarcopenia research (20122025): a multi-database bibliometric analysis Keyan Gao, Liwen Xun, Shalei Hao, Min An, Lingfeng Zuo, Jiayu Wang, Ying Wang, Junhua He Frontiers in Nutrition .2026;[Epub] CrossRef Integrating UHPLC-Q-TOF/MS and multi-omics to elucidate the regulatory mechanisms of Xiong's Shiwei Wendan decoction in MASLD Miao Jiang, Qiu Wu, Rong Yu, Zehua Zhang, Ge Wen, Yuan Zhong, Zhoujin Tan, Zhijian Li, Xuejiao Xie Journal of Chromatography B .2026

Glucagon-like Peptide-1 Protects against Cardiac Microvascular Injury in Diabetes via a cAMP/PKA/Rho-dependent Mechanism

In the months that followed, a number of human studies were started, many of which are still under way

(5) Wessells H, Levine N, Hadley ME, Dorr R, Hruby V

Market Size & Highlights The GLP-1 analogues market reached US$ 51.6 Bn in 2024

This recognition has paved the way for scientifically backed treatments including advanced metabolic medications like GLP-1 and dual-agonist drugs